Login / Signup

Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.

Chuanjiang DongYueqing WangYi CaiYuhuang WuWei ChenLu WangXiaowen LiuLili ZouJun Wang
Published in: Drug design, development and therapy (2024)
effect of SM, and its synergistic combination showed low mammalian toxicity in vitro and in vivo. Further efforts are required to study the underlying mechanisms of EbSe as an antibiotic adjuvant in combination with anti-TB drug MS.
Keyphrases
  • early stage
  • mass spectrometry
  • mycobacterium tuberculosis
  • multiple sclerosis
  • ms ms
  • cancer therapy
  • drug induced
  • electron transfer